Background
Background A number of enhance-A number of enhancement strategies have been proposed to ment strategies have been proposed to improve the quality and outcome of care improve the quality and outcome of care for depression in primary care settings. for depression in primary care settings. Decision-makers arelikely to need to know Decision-makers are likely to need to know whether these interventions are costwhether these interventions are costeffective in routine primary care settings. effective in routine primary care settings.
Method Method We conducted a systematic
We conducted a systematic reviewof allfulleconomicevaluations (costreviewof allfulleconomicevaluations (costeffectiveness and cost^utility analyses) effectiveness and cost^utility analyses) accompanyingrandomisedcontrolledtrials accompanyingrandomisedcontrolledtrials of enhanced primary care for depression. of enhanced primary care for depression. Costs were standardised to UK pounds/ Costs were standardised to UK pounds/ US dollars and incremental cost-US dollars and incremental costeffectiveness ratios (ICERs) were visually effectiveness ratios (ICERs) were visually summarised using a permutation matrix. summarised using a permutation matrix.
Results

Results We identified11full economic
We identified11full economic evaluations (4757 patients). A nearevaluations (4757 patients). A nearuniform finding was thatthe interventions uniform finding was thatthe interventions based upon collaborative care/case based upon collaborative care/case management resulted in improved outmanagement resulted in improved outcomes but were also associated with comes but were also associated with greater costs.When considering primary greater costs.When considering primary care depression treatment costs alone, care depression treatment costs alone, ICER estimates ranged from »7 ($13, no ICER estimates ranged from »7 ($13, no confidence interval given) to »13 ($24,95% confidence interval given) to »13 ($24,95% CI CI7 7105 to148) per additional depression-105 to148) per additional depressionfree day.Educational interventions alone free day.Educational interventions alone were associated with increased cost and were associated with increased cost and no clinical benefit. no clinical benefit.
Conclusions Conclusions Improved outcomes
Improved outcomes through depression management prothrough depression management programmes using a collaborative care/case grammes using a collaborative care/case management approach can be expected, management approach can be expected, but are associated with increased cost and but are associated with increased cost and will require investment. will require investment.
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A number of organisational and A number of organisational and educational strategies have been proposed educational strategies have been proposed to improve the recognition and manageto improve the recognition and management of depression in primary care ment of depression in primary care (Gilbody (Gilbody et al et al, 2003; Bower & Gilbody, , 2003; Bower & Gilbody, 2005) . These include educative strategies 2005). These include educative strategies targeted at primary care physicians; clinical targeted at primary care physicians; clinical practice guidelines and a range of strategies practice guidelines and a range of strategies to implement them (Cabana to implement them (Cabana et al et al, 2002) ; , 2002); and collaborative care, involving an and collaborative care, involving an enhanced case management role for nonenhanced case management role for nonmedical specialists such as practice nurses medical specialists such as practice nurses and integrated working relationships and integrated working relationships between primary care and specialist/ between primary care and specialist/ secondary services (Katon secondary services (Katon et al et al, 2001 (Katon et al et al, , 2001b . ). In the UK, educational interventions In the UK, educational interventions based upon consensus guidelines have based upon consensus guidelines have formed the cornerstone of quality improveformed the cornerstone of quality improvement strategies, such as the Defeat Depresment strategies, such as the Defeat Depression Campaign (Paykel & Priest, 1992) . sion Campaign (Paykel & Priest, 1992) . More recently more intensive organisaMore recently more intensive organisational strategies such as case management tional strategies such as case management and stepped care have been cautiously and stepped care have been cautiously recommended by the National Institute recommended by the National Institute for Clinical Excellence (2004) . In addition, for Clinical Excellence (2004) . In addition, there are specific governmental initiatives there are specific governmental initiatives to encourage primary care physicians to to encourage primary care physicians to provide 'enhanced care' for depression provide 'enhanced care' for depression (National Institute for Mental Health in (National Institute for Mental Health in England, 2004) , with economic incentives England, 2004) , with economic incentives attached. attached.
Decision-makers increasingly seek Decision-makers increasingly seek information on both clinical effectiveness information on both clinical effectiveness and and cost-effectiveness, in order to make cost-effectiveness, in order to make optimal decisions about the use of optimal decisions about the use of limited healthcare resources (NHS limited healthcare resources (NHS Centre for Reviews and Dissemination, Centre for Reviews and Dissemination, 2001 2001a a) . Systematic reviews of randomised ). Systematic reviews of randomised controlled trials are considered the controlled trials are considered the highest quality source of research highest quality source of research evidence, but this method of data synthesis evidence, but this method of data synthesis has not hitherto been applied to economic has not hitherto been applied to economic data in this area of practice and policy. data in this area of practice and policy. We therefore conducted a systematic We therefore conducted a systematic review of economic evaluations of review of economic evaluations of methods of organising and delivering methods of organising and delivering enhanced primary healthcare for enhanced primary healthcare for depression. depression.
METHOD METHOD
We conducted a systematic review of ecoWe conducted a systematic review of economic studies according to accepted guidenomic studies according to accepted guidelines (NHS Centre for Reviews and lines (NHS Centre for Reviews and Dissemination, 2001 Dissemination, 2001b b) , and specifically ), and specifically used a method proposed by Nixon used a method proposed by Nixon et al et al (2001) to summarise data from individual (2001) to summarise data from individual economic evaluations where meta-analysis economic evaluations where meta-analysis cannot routinely be applied. cannot routinely be applied.
Inclusion criteria Inclusion criteria
Economic studies were selected that exEconomic studies were selected that examined the cost-effectiveness of organisaamined the cost-effectiveness of organisational interventions to improve the quality tional interventions to improve the quality and outcome or care for depression in and outcome or care for depression in primary care settings. These organisational primary care settings. Studies that specifically examined the Studies that specifically examined the effectiveness of psychotherapy or drug effectiveness of psychotherapy or drug treatments alone (e.g. Lave treatments alone (e.g. Lave et al et al, 1998) , 1998) were not included, although many of the were not included, although many of the enhancements outlined above included enhancements outlined above included these as components of care. We sought these as components of care. We sought all full economic evaluations (cost-benefit all full economic evaluations (cost-benefit analyses, cost-effectiveness analyses, costanalyses, cost-effectiveness analyses, costminimisation analyses or cost-utility minimisation analyses or cost-utility analyses) based upon robust randomised analyses) based upon robust randomised epidemiological designs (Gold epidemiological designs (Gold et al et al, 1996; , 1996 (Bero et al et al, 1998) and , 1998 ) and optimal search strategies developed by the optimal search strategies developed by the National Health Service Centre for Reviews National Health Service Centre for Reviews and Dissemination (NHS Centre for and Dissemination (NHS Centre for Reviews and Dissemination, 2001 Reviews and Dissemination, 2001a a, ,b b). In ). In addition, we scrutinised the reference lists addition, we scrutinised the reference lists of all potentially relevant studies and of all potentially relevant studies and corresponded with authors of randomised corresponded with authors of randomised controlled trials for unpublished costcontrolled trials for unpublished costeffectiveness data. effectiveness data.
Data extraction and synthesis Data extraction and synthesis
The eligibility, design, content, quality and The eligibility, design, content, quality and results of all full economic evaluations were results of all full economic evaluations were judged against standard criteria (Drummond judged against standard criteria (Drummond & Jefferson, 1996 ; NHS Centre for Reviews & Jefferson, 1996 ; NHS Centre for Reviews and Dissemination, 2001 and Dissemination, 2001a a) . Main between-). Main betweengroup comparisons were considered in group comparisons were considered in preference to non-randomised subgroup preference to non-randomised subgroup analyses. All prices were converted to UK analyses. All prices were converted to UK pounds and US dollars using a common curpounds and US dollars using a common current exchange rate. A narrative overview of rent exchange rate. A narrative overview of interventions, key design features, results interventions, key design features, results and common methodological strengths and and common methodological strengths and weaknesses was conducted. We paid particuweaknesses was conducted. We paid particular attention to the use of appropriate lar attention to the use of appropriate Effectiveness: +, better; 0, same; Effectiveness: +, better; 0, same; 7 7, poorer. Cost: +, higher; 0, same; , poorer.Cost: +, higher; 0, same; 7 7, lower. , lower. 
2001b b). ). This method of analysis represents
This method of analysis represents incremental cost and incremental effectiveincremental cost and incremental effectiveness as a tabular refinement of the costness as a tabular refinement of the costeffectiveness plane (Black, 1990) , known effectiveness plane (Black, 1990) , known as a 'permutation plot' (Birch & Gaffni, as a 'permutation plot' (Birch & Gaffni, 1996 ). 1996 .
Briefly, the permutation plot visually Briefly, the permutation plot visually presents nine possible outcomes (see presents nine possible outcomes (see Fig. 1 ), and links to the issues of technical Fig. 1) , and links to the issues of technical and allocative and allocative efficiency (Donaldson efficiency (Donaldson et al et al, , 2002) . Interventions that are technically 2002). Interventions that are technically efficient (e.g. increased effectiveness at efficient (e.g. increased effectiveness at reduced cost) or inefficient (e.g. increased reduced cost) or inefficient (e.g. increased cost with reduced clinical effectiveness) cost with reduced clinical effectiveness) can be quickly identified. Studies that raise can be quickly identified. Studies that raise questions of allocative efficiency and requestions of allocative efficiency and require decisions about opportunity costs quire decisions about opportunity costs and resource allocation (e.g. increased and resource allocation (e.g. increased effectiveness obtained at increased cost, or effectiveness obtained at increased cost, or reduced effectiveness obtained at reduced reduced effectiveness obtained at reduced cost) are also identified. In constructing cost) are also identified. In constructing the permutation plot we used reported the permutation plot we used reported point estimates of the incremental costpoint estimates of the incremental costeffectiveness ratio (ICER) in the first ineffectiveness ratio (ICER) in the first instance. Where ICERs were not available, stance. Where ICERs were not available, and incremental cost and incremental effect and incremental cost and incremental effect were presented separately, we used these were presented separately, we used these data to position studies within a specific data to position studies within a specific permutation matrix sector. Where increpermutation matrix sector. Where incremental cost data, incremental effectiveness mental cost data, incremental effectiveness data or incremental cost-effectiveness ratios data or incremental cost-effectiveness ratios were given with confidence intervals, we were given with confidence intervals, we plotted only point estimates in the permutaplotted only point estimates in the permutation matrix, and highlighted confidence tion matrix, and highlighted confidence intervals in the data tables and in the text intervals in the data tables and in the text of our review. Since cost data are often of our review. Since cost data are often skewed (Briggs & Gray, 1998), we report skewed (Briggs & Gray, 1998), we report only differences and confidence intervals only differences and confidence intervals where an appropriate method of analysis where an appropriate method of analysis (such as bootstrapping) was used to (such as bootstrapping) was used to account for skewness, and highlight where account for skewness, and highlight where the issue of potentially skewed cost data the issue of potentially skewed cost data might have been ignored in the tables. might have been ignored in the tables.
RESULTS RESULTS
From 5873 references, our searches identiFrom 5873 references, our searches identified 11 full economic evaluations based fied 11 full economic evaluations based upon randomised designs, providing cliniupon randomised designs, providing clinical and cost-effectiveness estimates for cal and cost-effectiveness estimates for Table 1 and summary cost-effectiveness in Table 1 and summary cost-effectiveness data are shown in the permutation plot data are shown in the permutation plot (Fig. 1) . (Fig. 1) .
Models of care Models of care
The majority of studies were economic The majority of studies were economic evaluations of models of enhanced care evaluations of models of enhanced care for depression, based upon collaborative for depression, based upon collaborative care models, and were conducted within care models, and were conducted within the US healthcare system (Von Korff the US healthcare system (Von Korff et one study involved the use of brief teleone study involved the use of brief telephone contact by non-specialist nurses to phone contact by non-specialist nurses to facilitate concordance with medication, to facilitate concordance with medication, to monitor progress and to coordinate monitor progress and to coordinate follow-up (Simon follow-up (Simon et al et al, 2000) . In other , 2000). In other strategies, such as collaborative and strategies, such as collaborative and stepped care programmes, a case manager stepped care programmes, a case manager coordinated care between primary care coordinated care between primary care physicians and specialists, while offering physicians and specialists, while offering brief problem-focused psychosocial interbrief problem-focused psychosocial interventions (Von Korff ventions (Von Korff et al et al, 1998) . The most , 1998). The most comprehensive intervention was the comprehensive intervention was the Partners in Care study, which included Partners in Care study, which included screening, clinician and patient education, screening, clinician and patient education, guideline dissemination, case management guideline dissemination, case management and enhanced access to specialist care, and enhanced access to specialist care, including cognitive-behavioural therapy including cognitive-behavioural therapy (Schoenbaum (Schoenbaum et al et al, 2001) . , 2001).
Details of economic evaluations Details of economic evaluations
The majority of studies examined cost and The majority of studies examined cost and consequence from the perspective of the consequence from the perspective of the healthcare system or third-party payer. healthcare system or third-party payer.
Costs generally included all drug, Costs generally included all drug, depression and non-depression-related depression and non-depression-related primary care costs, together with the costs primary care costs, together with the costs of specialist referral. Several studies considof specialist referral. Several studies considered out-patient depression treatment costs ered out-patient depression treatment costs alone, before broadening the perspective alone, before broadening the perspective of the evaluation to include first all outof the evaluation to include first all outpatient treatment costs and then all health patient treatment costs and then all health service costs (e.g. Simon service costs (e.g. Simon et al et al, 2001 , 2001a a). Some ). Some studies broadened the perspective of the studies broadened the perspective of the economic evaluation by studying patient economic evaluation by studying patient and carer expenses and lost earnings and carer expenses and lost earnings through time in treatment (Schoenbaum through time in treatment (Schoenbaum et al et al, 2001; Pyne , 2001; Pyne et al et al, 2003) . No study , 2003) . No study considered unemployment benefits or lost considered unemployment benefits or lost earnings of patients as a consequence of illearnings of patients as a consequence of illness, or wider non-healthcare costs such as ness, or wider non-healthcare costs such as social security benefits and lost earnings of social security benefits and lost earnings of carers. The period of follow-up and time carers. The period of follow-up and time horizon of the economic evaluations was horizon of the economic evaluations was generally 6-12 months, although two stugenerally 6-12 months, although two studies did report cost and effectiveness data dies did report cost and effectiveness data at 24 months (Schoenbaum at 24 months (Schoenbaum et al et al, 2001) , 2001) and 28 months (Katon and 28 months (Katon et al et al, 2002) . , 2002). There was some degree of consistency There was some degree of consistency between studies in terms of the unit of between studies in terms of the unit of cost-effectiveness. Several studies (Simon cost-effectiveness. Several studies (Simon et al et al, 2000 (Simon et al et al, , 2001 , presented cost per quality-adjusted life-year (QALY) estimates quality-adjusted life-year (QALY) estimates by combining by combining population utility estimates population utility estimates with patientwith patient-level rating scores on the short level rating scores on the short form instruments (Brazier form instruments (Brazier et al et al, 1998; Su-, 1998; Sugar gar et al et al, 1998; Lenert , 1998; Lenert et al et al, 2000) . The , 2000) . The degree of uncertainty around estimates of degree of uncertainty around estimates of costcost-effectiveness was expressed within effectiveness was expressed within confidence limits in several studies, calcuconfidence limits in several studies, calculated through bootstrap analysis (Efron & lated through bootstrap analysis (Efron & Tibshirani, 1993) , or expressed through Tibshirani, 1993), or expressed through cost-effectiveness acceptability curves cost-effectiveness acceptability curves (Fenwick (Fenwick et al et al, 2002 ; see Table 1 ). , 2002; see Table 1 ).
Details of cost-effectiveness Details of cost-effectiveness estimates estimates
The great majority of studies (9 out of 11) The great majority of studies (9 out of 11) demonstrated improved clinical outcomes demonstrated improved clinical outcomes for depression management, and all demonfor depression management, and all demonstrated increased point estimates of costs strated increased point estimates of costs associated with caring for depression. associated with caring for depression. These results are summarised in the permuThese results are summarised in the permutation plot (Fig. 2) . tation plot (Fig. 2) .
Enhanced care programmes for newly Enhanced care programmes for newly diagnosed depression diagnosed depression
We found seven randomised economic We found seven randomised economic evaluations (Von Korff evaluations (Von Korff et al et al, 1998; Simon , 1998; Simon et al et al, 2000 Simon et al et al, , 2001 , Collaborative care approaches Collaborative care approaches attracted increased treatment costs assoattracted increased treatment costs associated with delivering the intervention and ciated with delivering the intervention and increased treatment costs in terms of inincreased treatment costs in terms of increased primary care visits, increased use creased primary care visits, increased use of antidepressant medication, and access of antidepressant medication, and access to secondary care. When considering prito secondary care. When considering primary care depression treatment costs alone, mary care depression treatment costs alone, estimates ranged from £7 ($13, no confiestimates ranged from £7 ($13, no confidence interval given) per depression-free dence interval given) per depression-free day (Simon day (Simon et al et al, 2000) to £13 ($24, , 2000) to £13 ($24, 95%CI 95%CI 7 7105 to 148) per depression-free 105 to 148) per depression-free day (Simon day (Simon et al et al, 2002) . When the perspec-, 2002). When the perspective of the evaluation was broadened in two tive of the evaluation was broadened in two studies (Simon studies (Simon et al et al, 2001 (Simon et al et al, , 2001b Liu ; Liu et al et al, , 2003) , there was some suggestion that in-2003), there was some suggestion that increased costs associated with the intervencreased costs associated with the intervention might be partially offset through tion might be partially offset through reduced use of other services, reducing the reduced use of other services, reducing the overall cost per depression-free day. In no overall cost per depression-free day. In no study was cost-offset through reduced study was cost-offset through reduced healthcare utilisation of an extent and healthcare utilisation of an extent and magnitude to make the overall programme magnitude to make the overall programme cost-saving and dominant. cost-saving and dominant.
In terms of studies examining cost per In terms of studies examining cost per QALY using tariffs from the short form QALY using tariffs from the short form instruments (Brazier instruments (Brazier et al et al, 1998; Lenert , 1998; Lenert et al et al, 2000) , estimates ranged from £8269 , 2000), estimates ranged from £8269 ($15 463, confidence interval not given) ($15 463, confidence interval not given) per QALY for a nurse-delivered case manper QALY for a nurse-delivered case management approach (Pyne agement approach (Pyne et al et al, 2003) to , 2003) to £19 483 ($36 467, confidence interval not £19 483 ($36 467, confidence interval not given) per QALY for a complex intervengiven) per QALY for a complex intervention to enhance medication management tion to enhance medication management (Schoenbaum (Schoenbaum et al et al, 2001) . Using a different , 2001). Using a different method for calculating QALYs (ascribing method for calculating QALYs (ascribing quality-adjusted weights to the number of quality-adjusted weights to the number of depression-free days; Lave depression-free days; Lave et al et al, 1998 Lave et al et al, ) in , 1998 ) in this study (Schoenbaum this study (Schoenbaum et al et al, 2001 ), 95% , 2001), 95% confidence intervals for case management confidence intervals for case management based around medication ranged from based around medication ranged from £8190 to £16 380 ($15 331 to $30 663), £8190 to £16 380 ($15 331 to $30 663), and for nurse-delivered therapy and case and for nurse-delivered therapy and case management from £5063 to £10 124 management from £5063 to £10 124 ($9478 to $18 953). ($9478 to $18 953).
In a series of cost-effectiveness ratio In a series of cost-effectiveness ratio acceptability estimates (Pyne acceptability estimates (Pyne et al et al, 2003) , 2003) using cost-effectiveness acceptability using cost-effectiveness acceptability thresholds, for a nurse-delivered case thresholds, for a nurse-delivered case management approach there was a 65% management approach there was a 65% probability that the cost-effectiveness of probability that the cost-effectiveness of the intervention was less than $20 000 per the intervention was less than $20 000 per QALY and a 91% probability that it was QALY and a 91% probability that it was less than $50 000 per QALY. less than $50 000 per QALY.
Enhanced care for treatment-resistant Enhanced care for treatment-resistant depression depression
We found one randomised economic evaWe found one randomised economic evaluation (reported in two papers: Simon luation (reported in two papers:
, 2001a a; Katon ; Katon et al et al, 2002) . , 2002). This stepped care approach, whereby This stepped care approach, whereby enhanced care was reserved for those who enhanced care was reserved for those who had not responded to initial management had not responded to initial management by their general practitioner, attracted by their general practitioner, attracted increased treatment costs in terms of increased treatment costs in terms of increased primary care visits, increased use increased primary care visits, increased use of antidepressant medication, and access of antidepressant medication, and access to secondary care (Simon to secondary care (Simon et al et al, 2001 , 2001a a). ). When out-patient costs alone were considWhen out-patient costs alone were considered, improved outcome was achieved at a ered, improved outcome was achieved at a cost of £11 ($21, 95% CI 8 to 126) per cost of £11 ($21, 95% CI 8 to 126) per depression-free day over 6 months. There depression-free day over 6 months. There was no evidence of cost offset when the perwas no evidence of cost offset when the perspective of the intervention was broadened spective of the intervention was broadened to include total out-patient costs -£14 to include total out-patient costs -£14 ($26, 95% CI ($26, 95% CI 7 710 to 213) per 10 to 213) per depression-free day -or total healthcare depression-free day -or total healthcare costs -£19 ($35, 95% CI costs -£19 ($35, 95% CI 7 752 to 388) 52 to 388) per depression-free day. Longer-term per depression-free day. Longer-term follow-up over 28 months from this same follow-up over 28 months from this same trial (Katon trial (Katon et al et al, 2002) demonstrated a , 2002) demonstrated a persistent clinical effect, and cost persistent clinical effect, and cost differences between groups had become differences between groups had become non-significant. However, the follow-up non-significant. However, the follow-up was limited by attrition and the low statiswas limited by attrition and the low statistical power of this single study made it tical power of this single study made it difficult to interpret this non-significant difficult to interpret this non-significant difference in costs. difference in costs.
Enhanced care to prevent relapse Enhanced care to prevent relapse in recurrent depression in recurrent depression
We found one randomised economic We found one randomised economic evaluation (Simon evaluation (Simon et al et al, 2002) . Case man-, 2002). Case management targeted at those with recurrent agement targeted at those with recurrent but remitted depression produced improved but remitted depression produced improved depression outcomes at 12 months. This depression outcomes at 12 months. This intervention attracted increased treatment intervention attracted increased treatment costs in terms of increased primary care costs in terms of increased primary care visits, increased use of antidepressant visits, increased use of antidepressant medication, and access to secondary care medication, and access to secondary care (Simon (Simon et al et al, 2002) . When out-patient costs , 2002). When out-patient costs alone were considered, improved outcome alone were considered, improved outcome was achieved at a cost of £13 ($24, 95% was achieved at a cost of £13 ($24, 95% CI CI 7 735 to 496) per depression-free day 35 to 496) per depression-free day over 12 months. There was some suggesover 12 months. There was some suggestion of cost offset when the perspective of tion of cost offset when the perspective of the intervention was broadened to include the intervention was broadened to include total out-patient costs -£8 ($15, 95% CI total out-patient costs -£8 ($15, 95% CI 7 735 to 248) per depression-free day -or 35 to 248) per depression-free day -or total healthcare costs -£0.5 ($1, 95% CI total healthcare costs -£0.5 ($1, 95% CI 7 752 to 388) per depression-free day. How-52 to 388) per depression-free day. However, wide confidence intervals prevented ever, wide confidence intervals prevented firm conclusions in this respect. firm conclusions in this respect.
Clinician education strategies Clinician education strategies
We found two randomised economic We found two randomised economic ) and showed no impact on the improved management or outimpact on the improved management or outcome of depression, but attracted increased come of depression, but attracted increased costs associated with the educational intercosts associated with the educational intervention. This is clearly ineffective and vention. This is clearly ineffective and technically inefficient. technically inefficient.
DISCUSSION DISCUSSION
The main finding of this review is that there The main finding of this review is that there is a large and rigorous body of clinical and is a large and rigorous body of clinical and economic research into the enhanced economic research into the enhanced management of depression in primary care. management of depression in primary care. Enhancements of care, such as case manEnhancements of care, such as case management and collaborative care, mostly agement and collaborative care, mostly produce improved outcomes but are assoproduce improved outcomes but are associated with increased direct healthcare costs ciated with increased direct healthcare costs over the short term (Von Korff over the short term (Von Korff et al et al, 1998; , 1998 First, the perspective of all these evaluaFirst, the perspective of all these evaluations was that of the healthcare provider tions was that of the healthcare provider and healthcare system. Depression has proand healthcare system. Depression has profound economic consequences, in terms of found economic consequences, in terms of direct and indirect costs both to the individdirect and indirect costs both to the individual and to wider society (Greenberg ual and to wider society (Greenberg et al et al, , 2003; Thomas & Morris, 2003) , and a con-2003; Thomas & Morris, 2003) , and a consideration of these perspectives is generally sideration of these perspectives is generally more useful to policy makers (Gold more useful to policy makers (Gold et al et al, , 1996) . There is a possibility that this broad-1996) . There is a possibility that this broader economic perspective might demonstrate er economic perspective might demonstrate a higher degree of cost offset and technical a higher degree of cost offset and technical efficiency, and there was some evidence efficiency, and there was some evidence from some evaluations that might indeed from some evaluations that might indeed be the case (e.g. Simon be the case (e.g. Simon et al et al, 2002; Liu , 2002; Liu et al et al, 2003) . There is now emerging evi-, 2003) . There is now emerging evidence from randomised controlled trials dence from randomised controlled trials (e.g. Schoenbaum (e.g. Schoenbaum et al et al, 2001; Rost , 2001; Rost et al et al, , 2004 ) that unemployment is reduced and 2004) that unemployment is reduced and economic productivity increased as a conseeconomic productivity increased as a consequence of case management approaches. quence of case management approaches. These effects deserve to be incorporated into These effects deserve to be incorporated into future randomised economic evaluations. future randomised economic evaluations. Similarly, most of the studies examined Similarly, most of the studies examined cost-effectiveness over a 6-to 12-month cost-effectiveness over a 6-to 12-month perspective. One study that examined costs perspective. One study that examined costs and consequence over a 28-month period and consequence over a 28-month period did suggest that excess costs associated with did suggest that excess costs associated with enhanced care in the short term had disenhanced care in the short term had disappeared over time (Katon appeared over time (Katon et al et al, 2002 ). This , 2002 . This raises the possibility that the benefits of raises the possibility that the benefits of front-loaded intervention costs might be front-loaded intervention costs might be realised over a longer period of follow-up. realised over a longer period of follow-up. It should be noted that longer-term clinical It should be noted that longer-term clinical benefits of enhanced care for depression benefits of enhanced care for depression have begun to emerge (up to 5 years; have begun to emerge (up to 5 years; Wells Wells et al et al, 2004) , although longer-term , 2004), although longer-term cost-effectiveness has not been reported at cost-effectiveness has not been reported at the time of writing. Further research into the time of writing. Further research into the longer-term cost and consequences is the longer-term cost and consequences is justified. justified.
A second limitation of this research evi-A second limitation of this research evidence is the failure to produce a common dence is the failure to produce a common metric in terms of unit of cost-effectiveness metric in terms of unit of cost-effectiveness to allow comparisons between competing to allow comparisons between competing programmes (Torgerson & Rafterty, programmes (Torgerson & Rafterty, 1999) . A substantial proportion of evalua-1999). A substantial proportion of evaluations used cost per depression-free day as tions used cost per depression-free day as the unit of cost-effectiveness. This measure the unit of cost-effectiveness. This measure has intuitive clinical and economic meanhas intuitive clinical and economic meaning, and might be adopted across intervening, and might be adopted across interventions. It is also commendable that tions. It is also commendable that attempts have been made to incorporate attempts have been made to incorporate preference-based measures and to establish preference-based measures and to establish cost per QALY for certain interventions. cost per QALY for certain interventions. The inherent appeal of this measure is the The inherent appeal of this measure is the possibility of comparing net benefit across possibility of comparing net benefit across disease categories and interventions, in disease categories and interventions, in order to make more rational decisions order to make more rational decisions about resource allocation and prioritisation about resource allocation and prioritisation (Torgerson & Rafterty, 1999) . The notion (Torgerson & Rafterty, 1999) . The notion of how best to measure QALYs in the case of how best to measure QALYs in the case of depression is far from clear (Sherbourne of depression is far from clear (Sherbourne et al et al, 2001 ) and some of the findings in this , 2001) and some of the findings in this review demonstrate the inconsistency of review demonstrate the inconsistency of findings according to the method used. This findings according to the method used. This is an area that deserves further research. is an area that deserves further research.
The third and main issue is about The third and main issue is about deciding whether enhanced care should be deciding whether enhanced care should be funded, based on these cost-effectiveness funded, based on these cost-effectiveness data. Decision-makers in this case are data. Decision-makers in this case are fortunate in having recourse to a fortunate in having recourse to a strong body of research literature on coststrong body of research literature on costeffectiveness to use within their decisioneffectiveness to use within their decisionmaking process -in deciding priorities making process -in deciding priorities within healthcare systems and within menwithin healthcare systems and within mental health services. The overriding message tal health services. The overriding message of this systematic review is that there is a of this systematic review is that there is a substantial opportunity to improve the outsubstantial opportunity to improve the outcomes of depression, and that primary care comes of depression, and that primary care quality improvement strategies involving quality improvement strategies involving collaborative care and case management collaborative care and case management are a strong candidate approach. However, are a strong candidate approach. However, improving depression outcomes will require improving depression outcomes will require a substantial investment of funds. When a substantial investment of funds. When considering cost per QALY estimates, we considering cost per QALY estimates, we note that the health benefit that might be note that the health benefit that might be expected within a certain cost threshold is expected within a certain cost threshold is comparable with other interventions that comparable with other interventions that are funded from within healthcare systems. are funded from within healthcare systems. In a review of the population-level impact In a review of the population-level impact of mental health interventions, Andrews of mental health interventions, Andrews and colleagues (2000, 2004) demonstrated and colleagues (2000, 2004) demonstrated that interventions with similar levels of that interventions with similar levels of expected health gain to those presented in expected health gain to those presented in this review can substantially reduce the this review can substantially reduce the population burden of illness and disability population burden of illness and disability within existing healthcare budgets. within existing healthcare budgets.
It has now been comprehensively deIt has now been comprehensively demonstrated that educational interventions monstrated that educational interventions have minimal impact on clinical outcomes, have minimal impact on clinical outcomes, unless they are supported by enhancements unless they are supported by enhancements of care (Gilbody of care (Gilbody et al et al, 2003) . In addition, , 2003) . In addition, we have clearly demonstrated that clinician we have clearly demonstrated that clinician education packages, when delivered alone, education packages, when delivered alone, are a cost-ineffective strategy -bestowing are a cost-ineffective strategy -bestowing no improved outcome at an increased no improved outcome at an increased cost. Educational strategies only become cost. Educational strategies only become effective when they are combined with an effective when they are combined with an enhancement of care such as case manageenhancement of care such as case management. There is no case for further investment. There is no case for further investment in packages based solely upon an ment in packages based solely upon an educational design. Our review summarises educational design. Our review summarises cost-effectiveness data from two randomcost-effectiveness data from two randomised studies of educational interventions ised studies of educational interventions (Thompson (Thompson et al et al, 2000; Gask , 2000; Gask et al et al, 2004 Gask et al et al, ), , 2004 ), but should also be considered in the context but should also be considered in the context of a much larger body of evidence from of a much larger body of evidence from randomised trials (Gilbody randomised trials (Gilbody et al et al, 2003) . , 2003). Fourth, the vast majority of economic Fourth, the vast majority of economic data relating to collaborative care presented data relating to collaborative care presented within this review are derived from the within this review are derived from the USA. This raises questions about the degree USA. This raises questions about the degree to which cost-effectiveness estimates of to which cost-effectiveness estimates of collaborative care and case management collaborative care and case management can be translated to other healthcare syscan be translated to other healthcare systems and settings. One reason to be cautems and settings. One reason to be cautious about this aspect is the fact that tious about this aspect is the fact that many depression management programmes many depression management programmes evaluated within this review have been deevaluated within this review have been designed within a US managed-care system. signed within a US managed-care system. , 2003) . At the time of writing the cost-2003). At the time of writing the costeffectiveness of these clinically effective effectiveness of these clinically effective non-US studies had not been reported. In non-US studies had not been reported. In the interim, tech the interim, technologies are available to nologies are available to examine costexamine cost-effectiveness between differeffectiveness between different healthcare systems, for example by ent healthcare systems, for example by combining clinical effectiveness estimates combining clinical effectiveness estimates from these trials with routine service use from these trials with routine service use and cost data from another healthcare setand cost data from another healthcare setting, using decision modelling (Petitti, ting, using decision modelling (Petitti, 2000) . Our review identifies candidate in-2000). Our review identifies candidate interventions that can be further evaluated terventions that can be further evaluated from the perspective of other systems and from the perspective of other systems and settings. settings.
The final issue relates to the methods The final issue relates to the methods that have been used to summarise the that have been used to summarise the cost-effectiveness literature in this review. cost-effectiveness literature in this review. We used a method of literature synthesis We used a method of literature synthesis that had hitherto not been applied in this that had hitherto not been applied in this or any other area of mental health. or any other area of mental health. Through the use of extensive literature Through the use of extensive literature searches and an explicit framework of consearches and an explicit framework of considering the quality of the economic evisidering the quality of the economic evidence, we have collated and summarised a dence, we have collated and summarised a large and important body of research evilarge and important body of research evidence, using systematic review methoddence, using systematic review methodology (Gilbody & Petticrew, 1999) . ology (Gilbody & Petticrew, 1999) . Further, through the use of innovative Further, through the use of innovative methods of presenting economic data such methods of presenting economic data such as the permutation plot (Nixon as the permutation plot (Nixon et al et al, , 2001 ), we believe we have simplified a 2001), we believe we have simplified a complex and heterogeneous body of recomplex and heterogeneous body of research evidence to make it understandable search evidence to make it understandable for both experts and non-experts alike. Unfor both experts and non-experts alike. Unfortunately, the permutation plot loses fortunately, the permutation plot loses much of the interesting detail of individual much of the interesting detail of individual economic studies, such as the distribution economic studies, such as the distribution of costs and effects, when point estimates of costs and effects, when point estimates only are plotted in sectors of the costonly are plotted in sectors of the costeffectiveness plane. The results of the effectiveness plane. The results of the permutation matrix should therefore be permutation matrix should therefore be considered alongside more detailed results considered alongside more detailed results of individual studies, such as those of individual studies, such as those presented in data tables. However, the presented in data tables. However, the communication of complex health communication of complex health economic research to non-expert audiences economic research to non-expert audiences is essential in ensuring that economic is essential in ensuring that economic evidence is incorporated into rational evidence is incorporated into rational healthcare decision-making. healthcare decision-making.
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APPENDIX APPENDIX
Types of economic evaluations Types of economic evaluations
Adapted from NHS Centre for Reviews and Adapted from NHS Centre for Reviews and Dissemination (2001 Dissemination (2001a a). ). Full economic evaluations are studies in which a Full economic evaluations are studies in which a comparison of two or more treatments or care comparison of two or more treatments or care alternatives is undertaken and in which both alternatives is undertaken and in which both the costs and outcomes of the alternatives are the costs and outcomes of the alternatives are examined. examined.
Cost^benefit analysis Cost^benefit analysis
Cost and outcomes are measured in monetary Cost and outcomes are measured in monetary terms and used to calculate net monetary gains or terms and used to calculate net monetary gains or losses (presented as a cost^benefit ratio). Increaslosses (presented as a cost^benefit ratio). Increasingly used in calculating cost^benefit using the net ingly used in calculating cost^benefit using the net benefit approach: see McCrone benefit approach: see McCrone et al et al (2004) for an (2004) for an example. example.
Cost^utility analysis Cost^utility analysis
Measures the benefits of alternative treatments or Measures the benefits of alternative treatments or types of care by using utility measures such as types of care by using utility measures such as quality-adjusted life-years (QALYs) and may present quality-adjusted life-years (QALYs) and may present relative costs per QALY: see Pyne relative costs per QALY: see Pyne et al et al (2003 Pyne et al et al ( ) in this (2003 in this review for an example. review for an example.
Cost-effectiveness analysis Cost-effectiveness analysis
Compares interventions with a common or natural Compares interventions with a common or natural outcome (such as depression severity or outcome (such as depression severity or depression-free days) to discover which produces depression-free days) to discover which produces the maximum outcome for the same input of the maximum outcome for the same input of resources in a given population: see Simon resources in a given population: see Simon et al et al (2001 Simon et al et al ( (2001a 
